Extramural Funding
Overall, NCI obligations for its extramural program, which includes grants and contracts, totaled $4.88 billion in FY 2021.
- Obligations for grants totaled approximately 82.7% of extramural funding
- Obligations for contracts totaled approximately 17.3% of extramural funding
Obligations on this page include FY 2021 Cancer Moonshot funding and excludes fiscal years 2017 through 2020 Cures Moonshot carryover obligations.
| Mechanism | Amount | Percent |
|---|---|---|
| Research & Development (R&D) Contracts | $812,246,516 | 16.7% |
| Buildings and Facilities | 30,000,000 | 0.6% |
| Construction Contracts | 0 | 0.0% |
| Subtotal Contracts | $842,246,516 | 17.3% |
| Research Project Grants (RPGs) | 2,822,414,508 | 57.9% |
| Cancer Centers/Specialized Centers/SPORES | 563,521,069 | 11.6% |
| NRSA | 92,995,313 | 1.9% |
| Other Research Grants | 556,149,380 | 11.4% |
| Subtotal Grants | $4,035,080,270 | 82.7% |
| Total Extramural Funds | $4,877,326,786 | 100.0% |
| Intramural/RMS Funds | 1,565,408,450 | |
| Total NCI | $6,442,735,236 | |